| Year |
Citation |
Score |
| 2012 |
Wang H, Khor TO, Yang Q, Huang Y, Wu TY, Saw CL, Lin W, Androulakis IP, Kong AN. Pharmacokinetics and pharmacodynamics of phase II drug metabolizing/antioxidant enzymes gene response by anticancer agent sulforaphane in rat lymphocytes. Molecular Pharmaceutics. 9: 2819-27. PMID 22931102 DOI: 10.1021/Mp300130K |
0.54 |
|
| 2011 |
Wang H, Lin W, Shen G, Khor TO, Nomeir AA, Kong AN. Development and validation of an LC-MS-MS method for the simultaneous determination of sulforaphane and its metabolites in rat plasma and its application in pharmacokinetic studies. Journal of Chromatographic Science. 49: 801-6. PMID 22080809 DOI: 10.1093/Chrsci/49.10.801 |
0.489 |
|
| 2011 |
Lin W, Hong JL, Shen G, Wu RT, Wang Y, Huang MT, Newmark HL, Huang Q, Khor TO, Heimbach T, Kong AN. Pharmacokinetics of dietary cancer chemopreventive compound dibenzoylmethane in rats and the impact of nanoemulsion and genetic knockout of Nrf2 on its disposition. Biopharmaceutics & Drug Disposition. 32: 65-75. PMID 21341276 DOI: 10.1002/Bdd.734 |
0.548 |
|
| 2010 |
Wang H, Khor TO, Saw CL, Lin W, Wu T, Huang Y, Kong AN. Role of Nrf2 in suppressing LPS-induced inflammation in mouse peritoneal macrophages by polyunsaturated fatty acids docosahexaenoic acid and eicosapentaenoic acid. Molecular Pharmaceutics. 7: 2185-93. PMID 20831192 DOI: 10.1021/Mp100199M |
0.518 |
|
| 2010 |
Nair S, Barve A, Khor TO, Shen GX, Lin W, Chan JY, Cai L, Kong AN. Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells. Acta Pharmacologica Sinica. 31: 1223-40. PMID 20729872 DOI: 10.1038/Aps.2010.147 |
0.617 |
|
| 2009 |
Khor TO, Yu S, Barve A, Hao X, Hong JL, Lin W, Foster B, Huang MT, Newmark HL, Kong AN. Dietary feeding of dibenzoylmethane inhibits prostate cancer in transgenic adenocarcinoma of the mouse prostate model. Cancer Research. 69: 7096-102. PMID 19706764 DOI: 10.1158/0008-5472.Can-09-0597 |
0.38 |
|
| 2009 |
Keum YS, Khor TO, Lin W, Shen G, Kwon KH, Barve A, Li W, Kong AN. Pharmacokinetics and pharmacodynamics of broccoli sprouts on the suppression of prostate cancer in transgenic adenocarcinoma of mouse prostate (TRAMP) mice: implication of induction of Nrf2, HO-1 and apoptosis and the suppression of Akt-dependent kinase pathway. Pharmaceutical Research. 26: 2324-31. PMID 19669099 DOI: 10.1007/S11095-009-9948-5 |
0.645 |
|
| 2008 |
Lin W, Wu RT, Wu T, Khor TO, Wang H, Kong AN. Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochemical Pharmacology. 76: 967-73. PMID 18755157 DOI: 10.1016/J.Bcp.2008.07.036 |
0.527 |
|
| 2008 |
Barve A, Khor TO, Nair S, Lin W, Yu S, Jain MR, Chan JY, Kong AN. Pharmacogenomic profile of soy isoflavone concentrate in the prostate of Nrf2 deficient and wild-type mice. Journal of Pharmaceutical Sciences. 97: 4528-45. PMID 18236473 DOI: 10.1002/Jps.21311 |
0.462 |
|
| 2006 |
Hu R, Shen G, Yerramilli UR, Lin W, Xu C, Nair S, Kong AN. In vivo pharmacokinetics, activation of MAPK signaling and induction of phase II/III drug metabolizing enzymes/transporters by cancer chemopreventive compound BHA in the mice. Archives of Pharmacal Research. 29: 911-20. PMID 17121188 DOI: 10.1007/Bf02973914 |
0.59 |
|
| 2006 |
Nair S, Xu C, Shen G, Hebbar V, Gopalakrishnan A, Hu R, Jain MR, Lin W, Keum YS, Liew C, Chan JY, Kong AN. Pharmacogenomics of phenolic antioxidant butylated hydroxyanisole (BHA) in the small intestine and liver of Nrf2 knockout and C57BL/6J mice. Pharmaceutical Research. 23: 2621-37. PMID 16969697 DOI: 10.1007/S11095-006-9099-X |
0.664 |
|
| 2006 |
Xu C, Huang MT, Shen G, Yuan X, Lin W, Khor TO, Conney AH, Kong AN. Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2. Cancer Research. 66: 8293-6. PMID 16912211 DOI: 10.1158/0008-5472.Can-06-0300 |
0.572 |
|
| 2006 |
Hu R, Xu C, Shen G, Jain MR, Khor TO, Gopalkrishnan A, Lin W, Reddy B, Chan JY, Kong AN. Identification of Nrf2-regulated genes induced by chemopreventive isothiocyanate PEITC by oligonucleotide microarray. Life Sciences. 79: 1944-55. PMID 16828809 DOI: 10.1016/J.Lfs.2006.06.019 |
0.613 |
|
| 2006 |
Lin W, Shen G, Yuan X, Jain MR, Yu S, Zhang A, Chen JD, Kong AN. Regulation of Nrf2 transactivation domain activity by p160 RAC3/SRC3 and other nuclear co-regulators. Journal of Biochemistry and Molecular Biology. 39: 304-10. PMID 16756760 DOI: 10.5483/Bmbrep.2006.39.3.304 |
0.567 |
|
| 2006 |
Hu R, Xu C, Shen G, Jain MR, Khor TO, Gopalkrishnan A, Lin W, Reddy B, Chan JY, Kong AN. Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Cancer Letters. 243: 170-92. PMID 16516379 DOI: 10.1016/J.Canlet.2005.11.050 |
0.612 |
|
| 2006 |
Khor TO, Keum YS, Lin W, Kim JH, Hu R, Shen G, Xu C, Gopalakrishnan A, Reddy B, Zheng X, Conney AH, Kong AN. Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice. Cancer Research. 66: 613-21. PMID 16423986 DOI: 10.1158/0008-5472.Can-05-2708 |
0.65 |
|
| 2005 |
Shen G, Xu C, Hu R, Jain MR, Nair S, Lin W, Yang CS, Chan JY, Kong AN. Comparison of (-)-epigallocatechin-3-gallate elicited liver and small intestine gene expression profiles between C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Pharmaceutical Research. 22: 1805-20. PMID 16132347 DOI: 10.1007/S11095-005-7546-8 |
0.586 |
|
| 2004 |
Shen G, Hebbar V, Nair S, Xu C, Li W, Lin W, Keum YS, Han J, Gallo MA, Kong AN. Regulation of Nrf2 transactivation domain activity. The differential effects of mitogen-activated protein kinase cascades and synergistic stimulatory effect of Raf and CREB-binding protein. The Journal of Biological Chemistry. 279: 23052-60. PMID 15020583 DOI: 10.1074/Jbc.M401368200 |
0.642 |
|
| Show low-probability matches. |